VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot C6013AA: VAERS reports

23 VAERS reports list lot C6013AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2023-07-11 and 2024-10-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction862%
Allergic / Anaphylactic215%
Respiratory18%
Dermatological (non-injection-site)18%
General / Systemic (non-local)18%

Where reports came from

U.S. state of the reporter, where given (top 11).

Texas6
Michigan3
Alabama1
Florida1
Ohio1
Missouri1
North Carolina1
Massachusetts1
Indiana1
South Carolina1
Tennessee1

Reports by month received

2023-071
2023-084
2023-093
2023-113
2023-122
2024-031
2024-042
2024-075
2024-081
2024-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.